An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.

Inclusion Criteria:

• Baseline fasting serum TG level > 200mg/dL and <1000mg/dL, in subjects treated forHTG.
• If on previous statin therapy, the treatment should have been kept stable in the last 3 months before entering the study.
• Able and willing to give written informed consent.

Exclusion Criteria:

• Subjects taking fish oil capsules 8 weeks prior to inclusion in this study.
• Known allergy to the active ingredient, or fish, soya, corn or olive oild (placebos).
• Pregnant of lactating females.
• Known increased risk of hemorrhage such as recent surgery, gastrointestinalhemorrhagic disease.
• Significant hepatic disease.
• Significantly reduced renal function.
• Alcohol consumption >30g for male and 20g for female daily.
• Concomitant use of other investigational drugs.
• Subject related to the investigator.
• Subject expected to be not compliant.